Watch the newest installment in the Hands-On: Tips to Improve Diabetes Care webinar series.
Earn 1 FREE CE credit by completing this program!
OVERVIEW
Join fellow American Diabetes Association® (ADA) professional members for a live, one-hour panel discussion, Disease-Modifying Therapies and Cellular Therapies in Type 1 Diabetes.
This engaging session will explore the role of disease-modifying therapies in delaying or altering the progression of type 1 diabetes, review current and emerging cellular therapies and their clinical potential, and discuss the key challenges and future directions shaping the development and implementation of these innovative treatment approaches.
The session is part of the Hands On: Tips to Improve Diabetes Care webinar series, which is available exclusively to ADA professional members and presented by the ADA’s Behavioral Medicine & Psychology, Diabetes in Primary Care, Exercise Physiology, and Diabetes Technology Interest Groups. The series is supported by funding from The Leona M. and Harry B. Helmsley Charitable Trust.
LEARNING OBJECTIVES
Describe the role of disease-modifying therapies in delaying or altering the progression of type 1 diabetes.
Review current and emerging cellular therapies for type 1 diabetes and their clinical potential.
Discuss key challenges and future directions in the development and implementation of these therapies.
BENEFITS & CREDITS
1.0 CE Credit
DATE & TIME
September 8, 2026 from 3:00 PM - 4:00 PM ET
EXPIRATION DATE
November 8, 2026
Stephen Gitelman, MD
Mary B. Olney, MD / KAK Distinguished Professor in Pediatric Diabetes and Clinical Research
University of California San Francisco
Kevan Herold, MD
Professor of Medicine
Yale School of Medicine
Heba Ismail, MBBCH, PhD
Associate Professor of Pediatrics
Indiana University School of Medicine
Mary Pat Gallagher, MD
Associate Professor, Department of Pediatrics
NYU Grossman School of Medicine
The Leona M. and Harry B. Helmsley Charitable Trust